Delivery Order SPE2DB20D2014-SPE2DB23FC07V
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets in 100-count packages. The contract has a firm fixed price and a ceiling value of $33,529.91. It was awarded on January 15, 2025, with an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Plaquenil 200 mg tablets, a medication used to treat various conditions including malaria, lupus, and rheumatoid arthritis. The contract has a ceiling value of $14,841.40 and runs through February 22, 2023. It is a firm-fixed-price delivery order, with no set-aside designation,...
- This federal contract award, valued at $11,562.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Plaquenil 200 mg tablets, a medication used to treat malaria, lupus, and rheumatoid arthritis. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,706.79 delivery order contract is for the supply of Plaquenil 200 mg tablets. The contract has an ultimate completion date of April 5, 2023 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,553.40 firm-fixed-price contract is for the delivery of Plaquenil 200 mg tablets. The contract has a completion date of March 10, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Plaquenil 200 mg tablets, a medication used to treat various conditions including malaria, lupus, and rheumatoid arthritis. The contract has a ceiling value of $113,239.37 and is a Firm Fixed Price contract type, with an ultimate completion date of August 22, 2024. The contract was...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,820.34 firm fixed-price delivery order covers the supply of Plaquenil 200 mg tablets to support federal healthcare programs, with a completion date of September 2, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $90,494.47 firm fixed-price delivery order is for the supply of 4,560,160,597 units of Plaquenil 200 mg tablets. The award has a performance period through March 7, 2023 and was made without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,101.97 firm fixed-price delivery order is for the pharmaceutical product Plaquenil 200 mg Tablet, with a completion date of June 5, 2023. The contract was awarded on June 2, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FC07VDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,726.73, is for the delivery of Plaquenil 200 mg tablets, a medication used to treat certain medical conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 4/27/23 |